R-123942

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameR-123942

Drug Alias NameR-123942R-90324

ClassificationSmall molecules

Mechanisms of ActionFibroblast growth factor 2 inhibitorsAngiogenesis inhibitorsAnticancer protein kinase inhibitors +[4]

TargetsVascular endothelial growth factor receptorFibroblast growth factor 2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesJohnson & Johnson

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesJohnson & Johnson

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A